The Radiological Protection System - Steve Terada
Steve Terada
Masters Student, Nagasaki University
Department of Disaster Radiation Medical Sciences
Joint Graduate Course with Fukushima Medical University
pece_annotation_1473449061
tamar.rogoszinski- “…large-scale social forces—racism, gender inequality, poverty, political violence and war, and sometimes the very policies that address them—often determine who falls ill and who has access to care.”
- "the holy grail of modern medicine remains the search for the molecular basis of disease."
- "In some senses, the model is simple: clinical and community barriers to care are removed as diagnosis and treatment are declared a public good and made available free of charge to patients living in poverty."
- "The poor are the natural constituents of public health, and physicians ... are the natural attourneys of the poor."
pece_annotation_1480347111
tamar.rogoszinskiThis report does not address matters of disaster, but does dive into health issues faced by those discriminated against for being transgender and gender non-conforming.
pece_annotation_1473995548
tamar.rogoszinski- I first looked up travel to and from Liberia during the Ebola outbreak, since it had been seized. There was a ban, which has since been lifted after, but people coming to and from West Africa are still screened and recommended to visit physicians. As of mid-2015 there wa still a 21 day monitoring period needed. http://www.infectioncontroltoday.com/news/2015/05/cdc-downgrades-travel…'
- I was interested if there had been any progress on treatment for Ebola, but found that the main form of treatment is supportive care. Doctors are informed to provide IV fluid and ensure that the patient's immune response and other bodily functions are functioning properly. A vaccine is being worked on but has not gone through a trial to prove safety and effectiveness. https://www.cdc.gov/vhf/ebola/treatment/index.html
- I looked further into the vaccine being produced for Ebola. Currently, there is a combined phase 2 and phase 3 trial occurring in Sierra Leone called STRIVE (Sierra Leone Trial to Introduce a Vaccine against Ebola). The study is unblinded, so patients know whether or not they have received the vaccine. The vaccine is a rVSV-ZEBOV, or recombinant Vesicular Stomatitis Virus Zaire ebolavirus vaccine. This vaccine is also being used in phase 2 and phase 3 trials in Guinea and Liberia http://www.cdc.gov/vhf/ebola/strive/qa.html
pece_annotation_1480604242
tamar.rogoszinskiThe article's bibliography contains many references including the WHO, the Red Cross, and other organizations, as well as many other experts and professionals in the field.
pece_annotation_1474477424
tamar.rogoszinskiThe federal government funds OSHA.
pece_annotation_1473100283
harrison.leinweberOutside of this class and STS 6834 at Virgina Tech, it was difficult to find other places where this article was referenced. Because the article was published as part of a collection of articles related to this same topic, I assume that those who purchase the book for educational and research purposes read and discus the article at some length.
pece_annotation_1475202196
tamar.rogoszinskiThe convention in 1951 was a response to WW2 and the vast amounts of refugees that existed as a result. States involved in the convention and the UN could decide to apply it to refugees not necessarily from WW2, but in 1967, the limits were removed and made it so that it could apply to any refugees, not just those from WW2. It has since been used during major refugee crises in Africa, the Middle East, and Asia.
This case study report was developed in the class “Advanced Social Medicine'' in the Nagasaki University|Fukushima Medical University Joint Graduate School, Division of Disaster and Radiation Medic